Single-Use Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Single-Use Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

Single-Use Bioprocessing Market Outlook, Growth Drivers and Competitive Landscape

The global single-use bioprocessing market is expanding rapidly as biopharmaceutical manufacturers adopt flexible, scalable and cost-efficient production technologies. Valued at USD 30.12 billion in 2025, the market is projected to reach USD 122.92 billion by 2035, registering a compound annual growth rate of 15.1% from 2026 to 2035. This growth reflects the increasing integration of disposable bioprocessing systems across biologics development and commercial manufacturing workflows.

Lower capital requirements remain a primary factor supporting market expansion. Compared with conventional stainless-steel infrastructure, single-use bioprocessing systems reduce investment in fixed equipment while limiting cleaning, sterilization and validation requirements. Shorter installation and changeover times also improve operational agility, helping manufacturers accelerate development cycles, increase throughput and respond efficiently to changing production volumes.

Competitive Landscape and Recent Market Developments

The single-use bioprocessing market has an oligopolistic competitive structure led by Thermo Fisher Scientific, Sartorius, Danaher through its Cytiva business and Merck KGaA. Competition is centered on product innovation, integrated bioprocessing portfolios, manufacturing capacity and regional supply chain development. Leading suppliers are increasingly localizing production to reduce logistics risks, improve product availability and shorten lead times for biopharmaceutical customers.

In December 2025, the Telangana state government inaugurated Telangana 1 Bio in Genome Valley, India. The facility is dedicated to single-use bioprocess design and scale-up, highlighting increased institutional investment in advanced biomanufacturing infrastructure across emerging pharmaceutical hubs. In June 2025, Sartorius Stedim Biotech also expanded its cleanroom capacity to approximately 9,000 square meters, nearly doubling its previous footprint to address rising global demand for disposable bioprocessing products.

Key Single-Use Bioprocessing Market Drivers

The rising prevalence of chronic diseases, combined with an aging global population, is increasing demand for monoclonal antibodies, vaccines, cell therapies and other biologic medicines. Manufacturing these products requires tightly controlled processes with effective contamination prevention. Single-use systems support closed processing environments, rapid production scaling and reduced cross-contamination risk while minimizing downtime between batches.

Growth in personalized medicine, biosimilar development and outsourced biopharmaceutical manufacturing is also strengthening demand. Contract manufacturing organizations and contract research organizations benefit from disposable technologies because they can accommodate multiple products and batch sizes without extensive facility modifications. These capabilities are particularly valuable for clinical production, low-volume therapies and rapidly changing product pipelines.

Sustainability Opportunities and Regulatory Challenges

Sustainability is becoming an important area of innovation within the single-use bioprocessing industry. Although disposable systems generate plastic waste, manufacturers are investing in recyclable materials, waste-management programs and lifecycle optimization. The emerging Green Bio initiative reflects broader efforts to reduce environmental impact while maintaining the operational advantages of single-use manufacturing.

Regulatory scrutiny of leachables and extractables remains a notable barrier to market optimization. As disposable technologies expand into fill-finish operations and other sensitive applications, regulators, including the U.S. Food and Drug Administration, are requiring rigorous material testing, risk assessment and validation. These requirements can increase development costs and extend commercialization timelines, particularly for new materials and product configurations.

Market Segmentation Analysis

By workflow, upstream bioprocessing holds a leading market position due to the widespread use of single-use bioreactors in cell culture and fermentation. These systems support enhanced process control, faster turnaround and efficient capacity expansion. By product, simple and peripheral elements account for approximately 40% of market revenue. Tubing, filters, bags and connectors are essential to maintaining closed, contamination-resistant production environments.

By Product

By Workflow

By End Use

Regional Market Outlook

North America leads the global single-use bioprocessing market, supported by extensive biomanufacturing infrastructure, high healthcare expenditure and strong demand for biologic therapies. Regional manufacturers are frequently retrofitting existing facilities with disposable technologies rather than investing exclusively in new construction. This approach enables faster modernization, lower capital expenditure and greater production flexibility.

Europe remains a significant market due to its established biopharmaceutical sector and stringent manufacturing standards. Asia Pacific is expected to present substantial growth opportunities as governments and private companies increase investments in biologics production, contract manufacturing and research infrastructure. The market also encompasses the Middle East and Africa and South America, where expanding pharmaceutical capabilities are supporting gradual adoption.

Leading Single-Use Bioprocessing Companies

Looking ahead, sustained biologics demand, capacity expansion and supply chain regionalization are expected to support long-term single-use bioprocessing market growth. Continued advances in materials, automation, process analytics and sustainability will further influence competitive positioning as manufacturers pursue faster, safer and more adaptable biopharmaceutical production.

Key Attributes:

Key Topics Covered:

Chapter 1. Executive Summary: Global Single-Use Bioprocessing Market

Chapter 2. Report Description

2.1. Research Framework

2.1.1. Research Objective

2.1.2. Market Definitions

2.1.3. Market Segmentation

2.2. Research Methodology

2.2.1. Market Size Estimation

2.2.2. Qualitative Research

2.2.2.1. Primary & Secondary Sources

2.2.3. Quantitative Research

2.2.3.1. Primary & Secondary Sources

2.2.4. Breakdown of Primary Research Respondents, By Region

2.2.5. Data Triangulation

2.2.6. Assumption for Study

Chapter 3. Global Single-Use Bioprocessing Market Overview

3.1. Industry Value Chain Analysis

3.1.1. Raw Material Sourcing

3.1.2. Manufacturing and Assembly

3.1.3. Distributors

3.1.4. End Users

3.2. Industry Outlook

3.2.1. Global Biopharmaceutical Production Outlook

3.2.2. EXIM Analysis

3.2.3. Regulatory Framework

3.3. PESTLE Analysis

3.4. Porter's Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitutes

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Growth and Outlook

3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035

3.5.2. Pricing Analysis, By Product

3.6. Market Attractiveness Analysis

3.6.1. By Product

3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

4.1. Market Concentration Rate

4.2. Company Market Share Analysis (Value %), 2025

4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Single-Use Bioprocessing Market Analysis

5.1. Market Dynamics and Trends

5.1.1. Growth Drivers

5.1.2. Restraints

5.1.3. Opportunity

5.1.4. Key Trends

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)

5.2.1. By Product

5.2.1.1. Key Insights

5.2.1.1.1. Simple & Peripheral Elements

5.2.1.1.1.1. Tubing, Filters, Connectors, & Transfer Systems

5.2.1.1.1.2. Bags

5.2.1.1.1.3. Sampling Systems

5.2.1.1.1.4. Probes & Sensors

5.2.1.1.1.4.1. pH Sensor

5.2.1.1.1.4.2. Oxygen Sensor

5.2.1.1.1.4.3. Pressure Sensors

5.2.1.1.1.4.4. Temperature Sensors

5.2.1.1.1.4.5. Conductivity Sensors

5.2.1.1.1.4.6. Flow Sensors

5.2.1.1.1.4.7. Others

5.2.1.1.1.5. Others

5.2.1.1.2. Apparatus & Plants

5.2.1.1.2.1. Bioreactors

5.2.1.1.2.1.1. Upto 1000 L

5.2.1.1.2.1.2. Above 1000 L to 2000 L

5.2.1.1.2.1.3. Above 2000 L

5.2.1.1.2.2. Mixing, Storage, & Filling Systems

5.2.1.1.2.3. Filtration System

5.2.1.1.2.4. Chromatography Systems

5.2.1.1.2.5. Pumps

5.2.1.1.2.6. Others

5.2.1.1.3. Work Equipment

5.2.1.1.3.1. Cell Culture System

5.2.1.1.3.2. Syringes

5.2.1.1.3.3. Others

5.2.2. By Workflow

5.2.2.1. Key Insights

5.2.2.1.1. Upstream Bioprocessing

5.2.2.1.2. Fermentation

5.2.2.1.3. Downstream Bioprocessing

5.2.3. By End Use

5.2.3.1. Key Insights

5.2.3.1.1. Biopharmaceutical Manufacturers

5.2.3.1.2. CMOs & CROs

5.2.3.1.3. In-house Manufacturers

5.2.3.1.4. Academic & Clinical Research Institutes

5.2.4. By Region

5.2.4.1. Key Insights

5.2.4.1.1. North America

5.2.4.1.1.1. The U.S.

5.2.4.1.1.2. Canada

5.2.4.1.1.3. Mexico

5.2.4.1.2. Europe

5.2.4.1.2.1. Western Europe

5.2.4.1.2.1.1. The UK

5.2.4.1.2.1.2. Germany

5.2.4.1.2.1.3. France

5.2.4.1.2.1.4. Italy

5.2.4.1.2.1.5. Spain

5.2.4.1.2.1.6. Rest of Western Europe

5.2.4.1.2.2. Eastern Europe

5.2.4.1.2.2.1. Poland

5.2.4.1.2.2.2. Russia

5.2.4.1.2.2.3. Rest of Eastern Europe

5.2.4.1.3. Asia Pacific

5.2.4.1.3.1. China

5.2.4.1.3.2. India

5.2.4.1.3.3. Japan

5.2.4.1.3.4. South Korea

5.2.4.1.3.5. Australia & New Zealand

5.2.4.1.3.6. ASEAN

5.2.4.1.3.6.1.1. Indonesia

5.2.4.1.3.6.1.2. Malaysia

5.2.4.1.3.6.1.3. Thailand

5.2.4.1.3.6.1.4. Singapore

5.2.4.1.3.6.1.5. Rest of ASEAN

5.2.4.1.3.7. Rest of Asia Pacific

5.2.4.1.4. Middle East & Africa

5.2.4.1.4.1. UAE

5.2.4.1.4.2. Saudi Arabia

5.2.4.1.4.3. South Africa

5.2.4.1.4.4. Rest of MEA

5.2.4.1.5. South America

5.2.4.1.5.1. Argentina

5.2.4.1.5.2. Brazil

5.2.4.1.5.3. Rest of South America

Chapter 6. North America Single-Use Bioprocessing Market Analysis

6.1. Market Dynamics and Trends

6.1.1. Growth Drivers

6.1.2. Restraints

6.1.3. Opportunity

6.1.4. Key Trends

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)

6.2.1. By Product

6.2.2. By Workflow

6.2.3. By End Use

6.2.4. By Country

Chapter 7. Europe Single-Use Bioprocessing Market Analysis

7.1. Market Dynamics and Trends

7.1.1. Growth Drivers

7.1.2. Restraints

7.1.3. Opportunity

7.1.4. Key Trends

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)

7.2.1. By Product

7.2.2. By Workflow

7.2.3. By End Use

7.2.4. By Country

Chapter 8. Asia Pacific Single-Use Bioprocessing Market Analysis

8.1. Market Dynamics and Trends

8.1.1. Growth Drivers

8.1.2. Restraints

8.1.3. Opportunity

8.1.4. Key Trends

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)

8.2.1. By Product

8.2.2. By Workflow

8.2.3. By End Use

8.2.4. By Country

Chapter 9. Middle East & Africa Single-Use Bioprocessing Market Analysis

9.1. Market Dynamics and Trends

9.1.1. Growth Drivers

9.1.2. Restraints

9.1.3. Opportunity

9.1.4. Key Trends

9.2. Market Size and Forecast, 2020-2035 (US$ Mn)

9.2.1. By Product

9.2.2. By Workflow

9.2.3. By End Use

9.2.4. By Country

Chapter 10. South America Single-Use Bioprocessing Market Analysis

10.1. Market Dynamics and Trends

10.1.1. Growth Drivers

10.1.2. Restraints

10.1.3. Opportunity

10.1.4. Key Trends

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)

10.2.1. By Product

10.2.2. By Workflow

10.2.3. By End Use

10.2.4. By Country

Chapter 11. Company Profiles (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

11.1. ABEC Inc.

11.2. Avantor Inc.

11.3. Cellexus

11.4. Celltainer Biotech BV

11.5. ESCO Bioengineering Co.

11.6. Danaher Corp

11.7. Distek Inc.

11.8. Entegris Inc.

11.9. Eppendorf AG

11.10. GEA Group

11.11. Meissner Filtration Products

11.12. Merck

11.13. OmniBRx Biotechnologies

11.14. Parker Hannifin (Domnick Hunter)

11.15. PBS Biotech Inc.

11.16. Repligen Corporation

11.17. Saint-Gobain Life Sciences

11.18. Sartorius AG

11.19. Solventum

11.20. Thermo Fisher Scientific Inc.

11.21. Other Prominent Players

Chapter 12. Annexure

12.1. List of Secondary Sources

12.2. Key Country Markets - Macro Economic Outlook/Indicators

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/21jytm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment